NDC 68083-381

Irinotecan hydrochloide

Irinotecan Hydrochloide

Irinotecan hydrochloide is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Gland Pharma Limited. The primary component is Irinotecan Hydrochloride.

Product ID68083-381_a95d97af-1572-4668-be46-822ae973c93e
NDC68083-381
Product TypeHuman Prescription Drug
Proprietary NameIrinotecan hydrochloide
Generic NameIrinotecan Hydrochloide
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2019-11-18
Marketing CategoryANDA / ANDA
Application NumberANDA212993
Labeler NameGland Pharma Limited
Substance NameIRINOTECAN HYDROCHLORIDE
Active Ingredient Strength20 mg/mL
Pharm ClassesTopoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68083-381-01

1 VIAL, SINGLE-DOSE in 1 CARTON (68083-381-01) > 2 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2019-11-18
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
IRINOTECAN HYDROCHLORIDE20 mg/mL

Pharmacological Class

  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]

© 2019 FDA.report
This site is not affiliated with or endorsed by the FDA.